- Home
- RARE vs CCU Comparison
RARE vs CCU Comparison
Compare RARE & CCU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RARE | CCU |
|---|---|---|
| Founded | 2010 | 1850 |
| Country | United States | Chile |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 2013 | 2001 |
Fundamental Metrics
Financial Performance| Metric | RARE | CCU |
|---|---|---|
| Price | $22.28 | $11.63 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 19 | 2 |
| Target Price | ★ $59.32 | $12.00 |
| AVG Volume (30 Days) | ★ 2.0M | 223.8K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 2.02% |
| EPS Growth | ★ 7.31 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $673,000,000.00 | N/A |
| Revenue This Year | $13.12 | $9.77 |
| Revenue Next Year | $42.13 | $6.08 |
| P/E Ratio | ★ N/A | $18.35 |
| Revenue Growth | ★ 20.13 | N/A |
| 52 Week Low | $18.29 | $10.71 |
| 52 Week High | $40.17 | $15.75 |
Technical Indicators
Market Signals| Indicator | RARE | CCU |
|---|---|---|
| Relative Strength Index (RSI) | 56.66 | 45.85 |
| Support Level | $22.00 | $11.51 |
| Resistance Level | $23.44 | $12.38 |
| Average True Range (ATR) | 0.95 | 0.36 |
| MACD | 0.28 | 0.13 |
| Stochastic Oscillator | 99.76 | 83.95 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.
About CCU Compania Cervecerias Unidas S.A.
United Breweries Co Inc is a multi-category beverage company with operations in Chile, Argentina, Bolivia, Colombia, Paraguay and Uruguay. The company is a player in each one of the beverage categories in which it participates in Chile, including beer, soft drinks, mineral and bottled water, juice, wine, cider and pisco, among others. The Company has three operating segment with respect to its revenues in the geographic areas of commercial activity: Chile; International business and Wine. It generates maximum revenue from Chile.